Results
1
1 companies
argenx
Market Cap: €44.3b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€723.80
7D
0.7%
1Y
18.2%
